Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) is looking for M&A. Robert Koremans, Chief Executive Officer said, "We keep also enhancing our growth through value-accretive M&A activities, both in SPC and that is focused on Europe and in Rare Disease, which is global, and there will be focus also on the U.S. because that's where the biggest earnings and profit opportunities are in this business".